483
CorneaGen, Inc.CorneaGen, Inc. – FDA 483, Jul 29, 2022
Record Details
Corneagen, Inc. in South San Francisco, CA, a human tissue establishment, was cited for two significant observations during an FDA inspection. The firm failed to validate processing steps for its ocular allograft products, raising concerns about contamination and the spread of communicable diseases. Additionally, the environmental monitoring program for ocular tissue processing was deemed inadequate, as monitoring was not performed at each processing event.
View Company Profile
ID · b55b1715-158f-460d-a5f4-947987c7ca2e
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.